FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984976956> ?p ?o ?g. }

• W2984976956 endingPage "927" @default.
• W2984976956 startingPage "920" @default.
• W2984976956 abstract "18F-PI-2620 is a next-generation tau PET tracer that has demonstrated ability to image the spatial distribution of suspected tau pathology. The objective of this study was to assess the tracer biodistribution, dosimetry, and quantitative methods of 18F-PI-2620 in the human brain. Full kinetic modeling to quantify tau load was investigated. Noninvasive kinetic modeling and semiquantitative methods were evaluated against the full tracer kinetics. Finally, the reproducibility of PET measurements from test and retest scans was assessed. Methods: Three healthy controls (HCs) and 4 Alzheimer disease (AD) subjects underwent 2 dynamic PET scans, including arterial sampling. Distribution volume ratio (DVR) was estimated using full tracer kinetics (reversible 2-tissue-compartment [2TC] model and Logan graphical analysis [LGA]) and noninvasive kinetic models (noninvasive LGA [NI-LGA] and the multilinear reference tissue model [MRTM2]). SUV ratio (SUVR) was determined at different imaging windows after injection. The correlation between DVR and SUVR, effect size (Cohen's d), and test-retest variability (TRV) were evaluated. Additionally, 6 HCs received 1 tracer administration and underwent whole-body PET for dosimetry calculation. Organ doses and the whole-body effective dose were calculated using OLINDA 2.0. Results: A strong correlation was found across different kinetic models (R2 > 0.97) and between DVR(2TC) and SUVR between 30 and 90 min, with an R2 of more than 0.95. Secular equilibrium was reached at around 40 min after injection in most regions and subjects. TRV and effect size for SUVR across different regions were similar at 30-60 min (TRV, 3.8%; Cohen's d, 3.80), 45-75 min (TRV, 4.3%; Cohen's d, 3.77) and 60-90 min (TRV, 4.9%; Cohen's d, 3.73) and increased at later time points. Elimination was via the hepatobiliary and urinary systems. The whole-body effective dose was 33.3 ± 2.1 μSv/MBq for an adult female and 33.1 ± 1.4 μSv/MBq for an adult male, with a 1.5-h urinary bladder voiding interval. Conclusion:18F-PI-2620 exhibits fast kinetics, suitable dosimetry, and low TRV. DVR measured using the 2TC model with arterial sampling correlated strongly with DVR measured by NI-LGA, MRTM2, and SUVR. SUVR can be used for 18F-PI-2620 PET quantification of tau deposits, avoiding arterial blood sampling. Static 18F-PI-2620 PET scans between 45 and 75 min after injection provide excellent quantification accuracy, a large effect size, and low TRV." @default.
• W2984976956 created "2019-11-22" @default.
• W2984976956 creator A5001182989 @default.
• W2984976956 creator A5006871150 @default.
• W2984976956 creator A5021075936 @default.
• W2984976956 creator A5025268682 @default.
• W2984976956 creator A5025617472 @default.
• W2984976956 creator A5027866519 @default.
• W2984976956 creator A5033376711 @default.
• W2984976956 creator A5037230816 @default.
• W2984976956 creator A5043708471 @default.
• W2984976956 creator A5046378639 @default.
• W2984976956 creator A5050432695 @default.
• W2984976956 creator A5059197712 @default.
• W2984976956 creator A5061039914 @default.
• W2984976956 creator A5063769157 @default.
• W2984976956 creator A5073336819 @default.
• W2984976956 creator A5073538686 @default.
• W2984976956 creator A5086458638 @default.
• W2984976956 creator A5091194111 @default.
• W2984976956 date "2019-11-11" @default.
• W2984976956 modified "2023-09-26" @default.
• W2984976956 title "Evaluation of Dosimetry, Quantitative Methods, and Test–Retest Variability of ¹⁸F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain" @default.
• W2984976956 cites W1946923111 @default.
• W2984976956 cites W2030773481 @default.
• W2984976956 cites W2058046532 @default.
• W2984976956 cites W2111352290 @default.
• W2984976956 cites W2112278807 @default.
• W2984976956 cites W2559092651 @default.
• W2984976956 cites W2786084903 @default.
• W2984976956 cites W2885332589 @default.
• W2984976956 cites W2904433122 @default.
• W2984976956 cites W2909883195 @default.
• W2984976956 cites W2954051589 @default.
• W2984976956 cites W2955832512 @default.
• W2984976956 cites W2963098834 @default.
• W2984976956 cites W2984450782 @default.
• W2984976956 doi "https://doi.org/10.2967/jnumed.119.236240" @default.
• W2984976956 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7262221" @default.
• W2984976956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31712324" @default.
• W2984976956 hasPublicationYear "2019" @default.
• W2984976956 type Work @default.
• W2984976956 sameAs 2984976956 @default.
• W2984976956 citedByCount "22" @default.
• W2984976956 countsByYear W29849769562019 @default.
• W2984976956 countsByYear W29849769562020 @default.
• W2984976956 countsByYear W29849769562021 @default.
• W2984976956 countsByYear W29849769562022 @default.
• W2984976956 countsByYear W29849769562023 @default.
• W2984976956 crossrefType "journal-article" @default.
• W2984976956 hasAuthorship W2984976956A5001182989 @default.
• W2984976956 hasAuthorship W2984976956A5006871150 @default.
• W2984976956 hasAuthorship W2984976956A5021075936 @default.
• W2984976956 hasAuthorship W2984976956A5025268682 @default.
• W2984976956 hasAuthorship W2984976956A5025617472 @default.
• W2984976956 hasAuthorship W2984976956A5027866519 @default.
• W2984976956 hasAuthorship W2984976956A5033376711 @default.
• W2984976956 hasAuthorship W2984976956A5037230816 @default.
• W2984976956 hasAuthorship W2984976956A5043708471 @default.
• W2984976956 hasAuthorship W2984976956A5046378639 @default.
• W2984976956 hasAuthorship W2984976956A5050432695 @default.
• W2984976956 hasAuthorship W2984976956A5059197712 @default.
• W2984976956 hasAuthorship W2984976956A5061039914 @default.
• W2984976956 hasAuthorship W2984976956A5063769157 @default.
• W2984976956 hasAuthorship W2984976956A5073336819 @default.
• W2984976956 hasAuthorship W2984976956A5073538686 @default.
• W2984976956 hasAuthorship W2984976956A5086458638 @default.
• W2984976956 hasAuthorship W2984976956A5091194111 @default.
• W2984976956 hasBestOaLocation W29849769561 @default.
• W2984976956 hasConcept C121332964 @default.
• W2984976956 hasConcept C185544564 @default.
• W2984976956 hasConcept C185592680 @default.
• W2984976956 hasConcept C202751555 @default.
• W2984976956 hasConcept C2775842073 @default.
• W2984976956 hasConcept C2777807558 @default.
• W2984976956 hasConcept C2778863792 @default.
• W2984976956 hasConcept C2779190346 @default.
• W2984976956 hasConcept C2989005 @default.
• W2984976956 hasConcept C43617362 @default.
• W2984976956 hasConcept C55493867 @default.
• W2984976956 hasConcept C60592354 @default.
• W2984976956 hasConcept C71924100 @default.
• W2984976956 hasConcept C75088862 @default.
• W2984976956 hasConcept C9893847 @default.
• W2984976956 hasConceptScore W2984976956C121332964 @default.
• W2984976956 hasConceptScore W2984976956C185544564 @default.
• W2984976956 hasConceptScore W2984976956C185592680 @default.
• W2984976956 hasConceptScore W2984976956C202751555 @default.
• W2984976956 hasConceptScore W2984976956C2775842073 @default.
• W2984976956 hasConceptScore W2984976956C2777807558 @default.
• W2984976956 hasConceptScore W2984976956C2778863792 @default.
• W2984976956 hasConceptScore W2984976956C2779190346 @default.
• W2984976956 hasConceptScore W2984976956C2989005 @default.
• W2984976956 hasConceptScore W2984976956C43617362 @default.
• W2984976956 hasConceptScore W2984976956C55493867 @default.
• W2984976956 hasConceptScore W2984976956C60592354 @default.
• W2984976956 hasConceptScore W2984976956C71924100 @default.
• W2984976956 hasConceptScore W2984976956C75088862 @default.

• next